These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1034919)

  • 21. [Change in dopamine and serotonin receptor sensitivity following chronic chlorpromazine administration].
    Zharkovskiĭ AM; Riago LK; Arro AG
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1980; 30(1):165-8. PubMed ID: 7189932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of drugs stimulating dopaminergic system on phosphodiesterase activity in rat striatum.
    Janiec W; Piekarska T; Szczypior M; Misterkiewicz E
    Pol J Pharmacol Pharm; 1976; 28(6):631-4. PubMed ID: 189292
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of naloxone and morphine on dopamine agonist-induced stereotypy in rats and guinea pigs.
    Feigenbaum J; Yanai J; Moon B; Klawans H
    Neuropharmacology; 1983 Dec; 22(12A):1369-76. PubMed ID: 6686653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of chronic amphetamine exposure on stereotyped behavior: implications for pathogenesis of l-dopa-induced dyskinesias.
    Klawans HL; Crossett P; Dana N
    Adv Neurol; 1975; 9():105-12. PubMed ID: 1170714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interrelations between dopaminergic and GABA-ergic transmitter mechanisms in apomorphine stereotypy.
    Markovska V; Georgiev V
    Acta Physiol Pharmacol Bulg; 1982; 8(3):67-73. PubMed ID: 6820612
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of memantine on central neurotransmitter systems. Review of the results].
    Maj J
    Arzneimittelforschung; 1982; 32(10):1256-9. PubMed ID: 6129854
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the D1-dopamine agonists SKF-38393 and A-68930 in neonatal 6-hydroxydopamine-lesioned rats: behavioral effects and induction of c-fos-like immunoreactivity.
    Johnson KB; Criswell HE; Jensen KF; Simson PE; Mueller RA; Breese GR
    J Pharmacol Exp Ther; 1992 Aug; 262(2):855-65. PubMed ID: 1354257
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Compounds stimulating central catecholamine receptors].
    Grabowska M
    Postepy Hig Med Dosw; 1973; 27(2):209-39. PubMed ID: 4787947
    [No Abstract]   [Full Text] [Related]  

  • 29. On some relationships between dopaminergic and serotoninergic mechanisms in pentylenetetrazol convulsions in albino mice.
    Lazarova M; Roussinov K
    Acta Physiol Pharmacol Bulg; 1979; 5(3):67-74. PubMed ID: 317212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Opposite modulation of apomorphine- or amphetamine-induced stereotypy by antagonists of CCK receptors.
    Tieppo CA; Ferreira FS; Sassatani AS; Felicio LF; Nasello AG
    Eur J Pharmacol; 2000 Jan; 387(2):189-96. PubMed ID: 10650159
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of ergometrine on methamphetamine and apomorphine stereotypy in the guinea-pig.
    Balsara JJ; Bapat TR; Gada VP; Nandal NV; Chandorkar AG
    J Pharm Pharmacol; 1985 Jul; 37(7):514-7. PubMed ID: 2863364
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced stereotyped response to amphetamine after pretreatment with small doses of molindone.
    Conway P; Uretsky NJ
    Neuropharmacology; 1983 May; 22(5):579-86. PubMed ID: 6308493
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of L-histidine and promethazine on apomorphine and amantadine stereotypy in rats.
    Balsara JJ; Dhavare BS; Nandal NV; Chandorkar AG
    Psychopharmacology (Berl); 1983; 79(4):372-4. PubMed ID: 6407056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of forebrain dopamine systems in amphetamine induced stereotyped behavior in the rat.
    Creese I; Iversen SD
    Psychopharmacologia; 1974; 39(4):345-57. PubMed ID: 4615333
    [No Abstract]   [Full Text] [Related]  

  • 35. Neuropeptide-dopamine interactions. II. Cyclo (His-Pro) augmentation of amphetamine- but not apomorphine-induced stereotypic behavior.
    Prasad C
    Behav Brain Res; 1988 Mar; 27(3):241-5. PubMed ID: 3358861
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reversal of the increase in apomorphine-induced stereotypy and aggression in REM sleep deprived rats by dopamine agonist pretreatments.
    Troncone LR; Ferreira TM; Braz S; Silveira Filho NG; Tufik S
    Psychopharmacology (Berl); 1988; 94(1):79-83. PubMed ID: 3126531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacological effects of 1,3-dimethyl-5-aminoadamantane, a new adamantane derivative.
    Maj J; Sowińska H; Baran L; Sarnek J
    Eur J Pharmacol; 1974 Apr; 26(1):9-14. PubMed ID: 4857604
    [No Abstract]   [Full Text] [Related]  

  • 38. Dopaminergic mechanisms and stereotyped behaviour in birds.
    Nistico' G; Stephenson JD
    Pharmacol Res Commun; 1979 Jul; 11(7):555-70. PubMed ID: 116248
    [No Abstract]   [Full Text] [Related]  

  • 39. A comparison between a melanocyte-stimulating hormone inhibitory factor (MIF-I) and substances known to activate central dopamine receptors.
    Cox B; Kastin AJ; Schnieden H
    Eur J Pharmacol; 1976 Mar; 36(1):141-7. PubMed ID: 4332
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine and dopamine-receptor stimulation.
    Dray A; Oakley NR
    J Pharm Pharmacol; 1976 Jul; 28(7):586-8. PubMed ID: 8616
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.